Hepatitis from Greater celandine (Chelidonium majus L.): Review of literature and report of a new case

Journal of Ethnopharmacology

Volumn 124, Issue 2, 2009, Pages 328-332

  Moro, Paola A ^a   Cassetti, Federica ^a   Giugliano, Gianni ^b   Falce, Maria T ^b   Mazzanti, Gabriela ^c   Menniti Ippolito, Francesca ^d   Raschetti, Roberto ^d   Santuccio, Carmela ^e  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Internal Medicine Department   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e ITALIAN MEDICINES AGENCY   (Italy)

Author keywords

Acute cholestatic hepatitis; Chelidonium majus; Complementary therapies; Greater celandine; Self medication

Indexed keywords

ALANINE AMINOTRANSFERASE; AMOXICILLIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHELIDONIUM EXTRACT; CLARITHROMYCIN; GLUTATHIONE; LANSOPRAZOLE; URSODEOXYCHOLIC ACID;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APPENDECTOMY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHRONIC GASTRITIS; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; HEARTBURN; HELICOBACTER INFECTION; HEPATOMEGALY; HIATUS HERNIA; HUMAN; JAUNDICE; LABORATORY TEST; LIVER INJURY; MALE; MEDICAL LITERATURE; PHYSICAL EXAMINATION; RISK BENEFIT ANALYSIS; STOMACH DISEASE; TOXIC HEPATITIS; TRADITIONAL MEDICINE;

ADMINISTRATION, ORAL; AGED; CHELIDONIUM; HEARTBURN; HEPATITIS, TOXIC; HUMANS; LIVER; MALE; PLANT PREPARATIONS;

CHELIDONIUM; CHELIDONIUM MAJUS;

EID: 67449161555     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.04.036     Document Type: Article

References (22)

1. Abt L., Lutz B., and Piscopo G. In: Klasco R.K. (Ed). Celandine-Alternative Medicine Evaluation vol. 137 (2002), AltMedDex, Greenwood Village, CO (expires 9/2008) (accessed May 5, 2008)
2. Benninger J., Schneider H.T., Shuppan D., Kirchner T., and Hahn E.G. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology 117 (1999) 1234-1237
3. Buzuk G.N., Lovkova M.Y., Sokolova S.M., and Tyutekin Y.V. Evaluation of the correlation and regression relationship between the concentrations of alkaloids and chemical elements in individual greater celandine (Chelidonium majus) plants. Doklady Biological Sciences 387 (2002) 562-564
4. Colombo M.L., and Bosisio E. Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacological Research 33 (1996) 127-134
5. Crijns A.P., de Smet P.A., van den Heuvel M., Schot B.W., and Haagsma E.B. Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus). Nederlands Tijdschrift voor Geneeskunde 146 (2002) 124-128
6. De Smet P.A.G.M. Safety concerns about kava not unique. Lancet 360 (2002) 1336
7. Ernst E., and Schmidt K. Ukrain-A New Cancer Cure? A Systematic Review of Randomised Clinical Trials vol. 5 (2005), BioMed Central Cancer p. 69
8. Etxenagusia M.A., Anda M., Gonzalez-Mahave I., Fernandez E., and Fernandez de Corres L. Contact dermatitis from Chelidonium majus (greater celandine). Contact Dermatitis 43 (2000) 47
9. European Directorate for the Quality of Medicines & HealthCare (EDQM), 2006. Monograph 1861: Chelidonii Herba. European Pharmacopoeia, 5th edition, EDQM, Strasbourg, pp. 1690-1691.
10. European Scientific Cooperative on Phytotherapy (ESCOP), 2003. Chelidonii Herba. Monographs. The Scientific Foundation of Herbal Medicinal Products, 2nd edition, Exeter and G. Thieme Verlag, Stuttgart and New York, pp. 74-78.
11. Greving I., Meister V., Monnerjahn C., Müller K.M., and May B. Chelidonium majus: a rare reason for severe hepatotoxic reaction. Pharmacoepidemiology and Drug Safety 7 (1998) S66-S69
12. Medicamenta, 1965. Cooperativa farmaceutica, vol. 3, 6th edition, Milano, pp. 2918-2919.
13. MHRA, 1997. List of herbal ingredients which are prohibited or restricted in medicines. Available from URL: http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&nodeId=1167 (accessed May 05, 2008).
14. Ministero della Salute, 2007. Lista piante non ammesse negli integratori alimentari, Available from URL: http://www.ministerosalute.it/alimenti/resources/documenti/dietetica/elenco_di_piante_e_derivati_giugno2006.pdf (accessed May 05, 2008).
15. Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology & Therapeutics 30 (1981) 239-245
16. Pieroni A., Dibra B., Grishaj G., Grishaj I., and Gjon Maçai S. Traditional phytotherapy of the Albanians of Lepushe, Northern Albanian Alps. Fitoterapia 76 (2005) 379-399
17. Reeks H.C. Poisoning of a cattle by common celandine. Journal of Complementary Pathology, Therapy and Toxicology 16 (1903) 367-371
18. Rifai K., Flemming P., Manns M.P., and Trautwein C. Severe drug hepatitis caused by Chelidonium. Internist 47 (2006) 749-751
19. Salgueiro E., Rubio T., Hidalgo A., and Manso G. Safety profile of proton pump inhibitors according to the spontaneous reports of suspected adverse reactions. International Journal of Clinical Pharmacology and Therapeutics 44 (2006) 548-556
20. Stickel F., Poschl G., Seitz H.K., Waldherr R., Hahn E.G., and Schuppan D. Acute hepatitis induced by Greater celandine (Chelidonium majus). Scandinavian Journal of Gastroenterology 38 (2003) 565-568
21. Then M., Szentmihalyi K., Sarkozi A., Illes V., and Forgacs E. Effect of sample handling on alkaloid and mineral content of aqueous extracts of greater celandine (Chelidonium majus L.). Journal of Chromatography A 889 (2000) 69-74
22. Viana de Miguel C., Alvarez Garcia M., Sanchez Sanchez A., and Carvajal Garcia-Pando A. Lansoprazole-induced hepatitis. Medicina Clínica 108 (1997) 599